📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-10-07 11:29
538 analysed today
FollowTelegram
538
Today
149,939
All-time analysed
42,983
Positive
6,669
Negative
91,579
Neutral
8,640
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
3 announcements match the current filters (relevance ≥ 5).
Kothari Fermentation Signs Commercial Pact With Rs 1,078 Cr Paid-Up Oriental Yeast India
Kothari Fermentation and Biochem Ltd (KFBL) has entered into commercial agreements on October 6, 2026, with Oriental Yeast India Private Limited (OYI), a subsidiary of Japan's Oriental Yeast Co. Ltd. Under the agreement, KFBL will provide manufacturing services, while OYI will provide technical support and distribution services for yeast and related products. There is no upfront consideration paid or received, and no change in management control. For KFBL, which generated Rs 119 Cr TTM revenue and has a market cap of Rs 62 Cr, partnering with an entity having a paid-up capital of Rs 1,078.05 Cr could improve manufacturing efficiency and product quality.
Confidence: HIGH
What changedKFBL formalised a domestic operational tie-up with Oriental Yeast India for mutual manufacturing, distribution, and technical support.
Why it mattersWith KFBL facing thin profitability (TTM PAT of Rs -2 Cr), technical assistance and broader distribution from a well-capitalised Japanese subsidiary could enhance product quality and capacity absorption.
Partner paid-up capital: Rs.1078.05 CroresAgreement date: 06/10/2026Upfront consideration: There is no upfront considerationKFBL TTM Revenue (Context): Rs 119 Cr
📅 Short termPositive sentiment driver given the scale of the counterparty, though immediate financial impact remains unquantified.
📈 Long termCould structurally aid KFBL's manufacturing efficiencies and distribution reach, potentially driving turnaround from recent annual net losses.
⚠ Risk flags
- No disclosed minimum volume commitments or revenue guarantees in the filing
- Execution risk in translating technical support into margin expansion
Key Highlights
Agreement executed on October 6, 2026, covering yeast and related products within the domestic market
Partner Oriental Yeast India Private Limited has a paid-up capital of Rs 1,078.05 Crores and is backed by Oriental Yeast Co. Ltd. (Japan)
KFBL will handle manufacturing services, while OYI will deliver technical support and distribution services
No upfront financial consideration involved, and zero impact on KFBL's management or control
👀 What to Watch
Track upcoming quarterly results to see if technical collaboration improves operating margins (OPM was 5.8% in FY26) or increases utilization via OYI's distribution network.
₹30.4 Cr Q1 Revenue: Kothari Fermentation Returns to Profitability YoY
Kothari Fermentation & Biochem reported a 28% YoY revenue growth to ₹30.41 Cr for Q1 FY27. The company achieved a marginal turnaround with a Net Profit of ₹6.45 Lakhs, compared to a loss of ₹1.12 Cr in the same quarter last year. However, performance weakened sequentially compared to Q4 FY26, where revenue was ₹32.47 Cr and PAT was ₹1.27 Cr. The company remains heavily reliant on its 'Yeast' segment, which now includes cattle feed synergies.
Confidence: HIGH
What changedThe company has transitioned from a loss-making Q1 in the previous fiscal year to a marginally profitable one, though it saw a sequential dip in both revenue and profit compared to the preceding March quarter.
Why it mattersFor a micro-cap company with a market cap of ₹65 Cr and a debt of ₹48 Cr, achieving consistent profitability is essential to manage its 0.89 debt-to-equity ratio and improve its ROCE from the current 0%.
Revenue (Q1 FY27): ₹30.41 CrYoY Revenue Growth: 28.0%Net Profit (Q1 FY27): ₹0.06 CrFinance Cost: ₹0.91 CrRevenue vs Market Cap: 46.7%
📅 Short termThe YoY turnaround is a positive signal, but the sequential decline in profit from ₹1.27 Cr to ₹0.06 Cr suggests volatility that may keep the stock price range-bound.
📈 Long termStructural improvement depends on the successful scaling of the cattle feed business and achieving better operating leverage to offset high power and fuel costs.
⚠ Risk flags
- Extremely thin net profit margins
- High finance costs relative to operating profit
- Significant sequential decline in profitability
Key Highlights
Revenue from operations increased 28% YoY to ₹30.41 Cr from ₹23.75 Cr.
Net Profit turned positive at ₹6.45 Lakhs vs a loss of ₹1.12 Cr in Q1 FY26.
Cost of materials consumed rose significantly to ₹15.40 Cr, up 44.7% from ₹10.64 Cr YoY.
Finance costs increased to ₹91.32 Lakhs from ₹79.57 Lakhs in the previous year's quarter.
The 36th Annual General Meeting (AGM) is scheduled for September 30, 2026.
👀 What to Watch
Investors should monitor the company's ability to maintain positive bottom-line results given the extremely thin margins (PAT margin < 0.3%). Watch for stabilization in raw material and power costs, which represent the bulk of expenses.
Rs 30.41 Cr Revenue: Kothari Fermentation Turns Profitable YoY in Q1 FY27
Kothari Fermentation & Biochem reported a 28% YoY increase in revenue to Rs 30.41 Cr for the quarter ended June 30, 2026. The company achieved a marginal net profit of Rs 6.45 Lakhs, a recovery from the Rs 1.12 Cr loss reported in the same quarter last year. However, profitability saw a significant sequential decline from the Rs 1.27 Cr profit recorded in March 2026. Operating margins remain extremely tight, with total expenses of Rs 30.41 Cr nearly equaling total income.
Confidence: HIGH
What changedThe company has transitioned from a loss-making Q1 in the previous year to a marginal profit, though it failed to maintain the higher profitability levels seen in the preceding March 2026 quarter.
Why it mattersFor a micro-cap company with a market cap of Rs 65 Cr and a D/E ratio of 0.89, achieving consistent profitability is essential for managing its Rs 48 Cr debt and improving its ROCE from 0%.
Revenue (Q1 FY27): Rs 30.41 CrNet Profit (Q1 FY27): Rs 0.06 CrYoY Revenue Growth: 28.0%Power & Fuel Cost: Rs 6.23 CrQuarterly EPS: Rs 0.04
📅 Short termThe YoY turnaround in profitability may provide some support to the stock price, but the sequential drop in earnings and thin margins are likely to temper investor enthusiasm.
📈 Long termThe company's long-term outlook depends on scaling its yeast and cattle feed operations to achieve better operating leverage, as current margins are highly sensitive to raw material and power costs.
⚠ Risk flags
- Extremely thin net margins (Profit before tax of only Rs 3.30 Lakhs on Rs 30.41 Cr revenue)
- High debt-to-equity ratio of 0.89
- High sensitivity to power and fuel costs
Key Highlights
Revenue from operations grew 28% YoY to Rs 30.41 Cr from Rs 23.75 Cr.
Net profit turned positive at Rs 6.45 Lakhs vs a loss of Rs 1.12 Cr in Q1 FY26.
Power and fuel costs remained a major expense at Rs 6.23 Cr, representing 20.5% of revenue.
Finance costs increased to Rs 0.91 Cr compared to Rs 0.80 Cr in the year-ago period.
The 36th Annual General Meeting (AGM) is scheduled for September 30, 2026.
👀 What to Watch
Investors should monitor the company's ability to improve operating margins, which are currently near break-even. The integration of the cattle feed segment with the core yeast business is the key structural development to track for future margin expansion.
